Who has invested in InventisBio?

Orbimed, CMB International Capital, GL Ventures are named among the investors backing InventisBio.

InventisBio Funding: $247M Raised, Series D (2020)

InventisBio funding overview

InventisBio is based in Shanghai, China. InventisBio has raised $247M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in September 2020. The round record for InventisBio runs through 2020; nothing later has been disclosed. Investors on record include Orbimed, CMB International Capital, GL Ventures. 3 distinct backers are named across the disclosed rounds.

InventisBio at a glance

Total raised: $247M
Latest round: Series D
Latest round date: September 2020
Headquarters: Shanghai, China
Notable investors: Orbimed, CMB International Capital, GL Ventures

Frequently asked about InventisBio funding

How much has InventisBio raised?: InventisBio has raised $247M in total disclosed funding across the rounds on record.
Who has invested in InventisBio?: Orbimed, CMB International Capital, GL Ventures are named among the investors backing InventisBio.
What was the latest InventisBio funding round?: The most recent disclosed round is a Series D, announced in September 2020.
Where is InventisBio based?: InventisBio is based in Shanghai, China.
When did InventisBio last raise?: The last disclosed InventisBio round closed in September 2020 at Series D.

Round data for InventisBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

InventisBio Funding: $247M Raised, Series D (2020)

InventisBio funding overview

InventisBio at a glance

Frequently asked about InventisBio funding

Companies related to InventisBio (25)

Browse related funding lists (7)